Range Low Price High Price Comment
30 days $36.77 $55.69 Wednesday, 1st May 2024 BHVN stock ended at $40.18. This is 3.56% more than the trading day before Tuesday, 30th Apr 2024. During the day the stock fluctuated 8.34% from a day low at $38.43 to a day high of $41.64.
90 days $36.77 $62.21
52 weeks $13.03 $62.21

Historical Biohaven Pharmaceutical Holding Company Ltd prices

Date Open High Low Close Volume
Jun 08, 2023 $22.49 $23.46 $22.42 $23.13 949 903
Jun 07, 2023 $22.71 $23.08 $22.03 $22.57 834 771
Jun 06, 2023 $21.90 $22.86 $21.36 $22.63 1 218 337
Jun 05, 2023 $22.00 $22.03 $21.22 $21.65 1 292 351
Jun 02, 2023 $21.15 $22.04 $20.03 $21.72 1 981 058
Jun 01, 2023 $18.20 $21.25 $17.86 $20.73 4 380 236
May 31, 2023 $16.31 $17.58 $16.30 $17.51 2 654 903
May 30, 2023 $15.79 $16.30 $15.58 $16.28 1 148 079
May 26, 2023 $15.48 $15.81 $15.07 $15.52 751 486
May 25, 2023 $15.91 $15.92 $14.96 $15.07 609 544
May 24, 2023 $16.62 $16.89 $15.36 $15.78 1 108 899
May 23, 2023 $15.85 $17.11 $15.76 $16.67 1 624 644
May 22, 2023 $14.19 $15.97 $14.25 $15.94 1 948 958
May 19, 2023 $14.04 $14.24 $13.59 $14.10 660 227
May 18, 2023 $14.07 $14.07 $13.54 $13.87 519 709
May 17, 2023 $14.16 $14.37 $13.71 $14.12 447 880
May 16, 2023 $14.25 $14.33 $13.66 $13.87 617 874
May 15, 2023 $13.81 $15.24 $13.73 $14.55 809 212
May 12, 2023 $13.82 $13.96 $13.46 $13.61 329 175
May 11, 2023 $14.15 $14.27 $13.51 $13.82 620 040
May 10, 2023 $14.70 $14.82 $14.01 $14.33 435 427
May 09, 2023 $14.10 $14.63 $13.97 $14.52 390 784
May 08, 2023 $14.25 $14.55 $14.03 $14.21 568 851
May 05, 2023 $13.90 $14.55 $13.87 $14.24 831 477
May 04, 2023 $13.57 $13.91 $13.03 $13.74 654 836
Click to get the best stock tips daily for free!

About Biohaven Pharmaceutical Holding Company Ltd

Biohaven Pharmaceutical Holding Company Ltd Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as developing Rimegepant for preventive treatment of migraine; Zavegepant that is in phase III clinical trials for acute and preventive treatment of migraine, as well as re... BHVN Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT